William Blair Shuffles Analyst Conviction List for April 2026 Apr 1, 2026 07:15AM
Xenon Pharmaceuticals closes $747.5 million public offering Mar 12, 2026 04:01PM
Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares Mar 12, 2026 04:01PM
Xenon Pharmaceuticals prices $650 million stock offering at $57 per share Mar 10, 2026 10:39PM
Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering Mar 10, 2026 10:39PM


Mar 9, 2026 04:01PM Xenon Pharmaceuticals announces $500 million public offering
Mar 9, 2026 04:01PM Xenon Pharmaceuticals Announces Proposed Public Offering
Mar 9, 2026 08:26AM William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE): "we see further room for upside"
Jul 13, 2022 04:11PM William Blair Reiterates Outperform Rating on Xenon Pharmaceuticals (XENE)
Jul 11, 2022 04:01PM Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022
Jul 11, 2022 04:01PM Xenon Pharmaceuticals to Present at the William Blair Biotech Focus Conference 2022
Jun 23, 2022 06:06AM Xenon's (XENE) XEN1101 Has Best in Class Potential, Company is Trading at Attractive Value - William Blair Bullish on Stock
Oct 4, 2021 08:56AM Xenon's (XENE) X-Tole Data as Good as it Gets with Best-in-Category Efficacy - Analyst
Jul 13, 2021 08:45AM Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
Jul 13, 2021 08:45AM Xenon Pharmaceuticals to Participate at the William Blair Biotech Focus Conference 2021
Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 12, 2021 12:19PM Xenon Pharmaceuticals Announces Closing of $115 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Mar 10, 2021 05:49AM Xenon Pharmaceuticals (XENE) Prices 4.32M Share Common Offering at $18.50/Sh
Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
Mar 10, 2021 12:49AM Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
Mar 9, 2021 04:05PM Xenon Pharmaceuticals (XENE) to Offer Common Stock
Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
Mar 9, 2021 04:04PM Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
Aug 4, 2020 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 4, 2020 04:01PM Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Jan 8, 2020 05:59AM William Blair Starts Xenon Pharmaceuticals (XENE) at Outperform